Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Stefan A. Dyckerhoff sold 7,814 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $107.17, for a total value of $837,426.38. Following the completion of the sale, the director now owns 121,803 shares in the company, valued at approximately $13,053,627.51. This trade represents a 6.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Astera Labs Stock Down 1.7 %
ALAB opened at $105.48 on Wednesday. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $113.85. The business has a 50 day moving average of $72.05 and a 200-day moving average of $60.30.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs’s revenue was up 47.1% on a year-over-year basis. Analysts forecast that Astera Labs, Inc. will post -0.45 EPS for the current year.
Analyst Ratings Changes
Read Our Latest Stock Analysis on ALAB
Institutional Trading of Astera Labs
A number of hedge funds have recently made changes to their positions in the business. Strategic Blueprint LLC lifted its position in shares of Astera Labs by 3.6% in the third quarter. Strategic Blueprint LLC now owns 5,684 shares of the company’s stock valued at $298,000 after buying an additional 195 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Astera Labs by 5.7% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock worth $277,000 after purchasing an additional 284 shares during the period. Hollencrest Capital Management bought a new position in shares of Astera Labs during the third quarter worth approximately $26,000. Venturi Wealth Management LLC increased its stake in shares of Astera Labs by 26.3% during the third quarter. Venturi Wealth Management LLC now owns 2,400 shares of the company’s stock worth $126,000 after purchasing an additional 500 shares during the period. Finally, US Bancorp DE bought a new position in shares of Astera Labs during the third quarter worth approximately $46,000.
Astera Labs Company Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Why Invest in High-Yield Dividend Stocks?
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.